Fig. 1: Dopamine (DA)–like agonist actions of phencyclidine and LY379268. (A) Phencyclidine recognized the high-affinity state of the D2 receptor, D2High, as labelled by [3H]domperidone. The presence of 200 μM guanylylimidodiphosphate abolished this high-affinity component, indicating the agonist nature of this phencyclidine-recognized state (reproduced with permission from Seeman P, Guan H-C. Phencyclidine and glutamate agonist LY379268 stimulate DA D2High receptors: D2 basis for schizophrenia. Synapse 2008;62:819-28. ©2008 Wiley-Liss, Inc.13). (B) Phencyclidine inhibited the release of prolactin from anterior pituitary cells in culture (reproduced with permission from Seeman P, Lasaga M. Dopamine agonist action of phenyclidine. Synapse 2005;58:275-7. ©2005 Wiley-Liss, Inc.14). (C) Phencyclidine stimulated the incorporation of [35S]GTP-γ-S in human cloned DA D2Long receptors (in CHO cells) in the absence of NaCl (top line), as well as in the presence of 120 mM NaCl which was about 25% of that compared with the absence of NaCl (30 min incubation) (modified, with permission13). (D) The glutamate agonist LY379268 recognized the high-affinity state of the D2 receptor, D2High, as labelled by [3H]domperidone. The presence of 200 μM guanylylimidodiphosphate abolished this high-affinity component, indicating the agonist nature of this drug-recognized state (with permission from Seeman P, Caruso C, Lasaga M. Dopamine partial agonist actions of the glutamate receptor agonists LY354740 and LY379268. Synapse 2008;62:154-8. ©2008 Wiley-Liss, Inc.16). (E) LY379268 directly inhibited the secretion of prolactin from anterior pituitary cells in culture (with permission16). (F) LY379268 stimulated the incorporation of [35S]GTP-γ-S into DA D2Long receptors, an effect selectively blocked by 10 μM of the D2 antagonist S-sulpiride (with permission16).